fulvestrant has been researched along with Cancer of Testis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boscia, F; Chieffi, P; Esposito, F; Franco, R; Fusco, A; Kitazawa, S; Looijenga, LH; Tornincasa, M | 1 |
| Bouskine, A; Carreau, S; Chevallier, D; Fenichel, P; Lambard, S; Mograbi, B; Nebout, M; Pointis, G; Roger, C | 1 |
2 other study(ies) available for fulvestrant and Cancer of Testis
| Article | Year |
|---|---|
Down-regulation of oestrogen receptor-β associates with transcriptional co-regulator PATZ1 delocalization in human testicular seminomas.
Topics: Antineoplastic Agents, Hormonal; Cell Nucleus; Cyclic AMP; Cytoplasm; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Transcription Factors; Male; Neoplasm Proteins; Repressor Proteins; Seminoma; Testicular Neoplasms; Translocation, Genetic; Tumor Cells, Cultured | 2011 |
Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase.
Topics: Aromatase; Base Sequence; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor beta; Estrogen Receptor Modulators; Fulvestrant; Gene Expression; Humans; Male; Seminoma; Testicular Neoplasms | 2005 |